$BIVI
BIOVIE INC. Stock $bivi

$bivi Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000152013822000437 Filed on September 27, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.007M	$3.362M	$9.765M
YoY Change	-24.1%	2762.77%	110.58%
% of Gross Profit
Research & Development	$6.770M	$5.873M	$17.26M
YoY Change	137.91%	-95.53%	-87.04%
% of Gross Profit
Depreciation & Amortization	$57.34K	$57.35K	$229.4K
YoY Change	0.0%	-3.42%	0.0%
% of Gross Profit
Operating Expenses	$8.834M	$9.292M	$27.25M
YoY Change	59.26%	-92.94%	-80.26%
Operating Profit	-$8.834M		-$27.25M
YoY Change	59.26%		-80.26%
Interest Expense	$1.056M	$1.203M	$2.163M
YoY Change	16053.15%	15813.89%	-72.06%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$10.42M	-$8.089M	-$26.08M
YoY Change	87.98%	-93.85%	-79.97%
Income Tax
% Of Pretax Income
Net Earnings	-$10.42M	-$8.089M	-$26.08M
YoY Change	87.98%	-93.85%	-79.97%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.38		-$1.06
Diluted Earnings Per Share	-$0.38	-$323.8K	-$1.06
COMMON SHARES
Basic Shares Outstanding	30.17M shares		24.66M shares
Diluted Shares Outstanding	27.21M shares		24.66M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.23M	$18.64M	$18.64M
YoY Change	3.63%	313.19%	313.19%
Cash & Equivalents	$21.23M	$18.64M
Short-Term Investments
Other Short-Term Assets	$359.1K	$137.9K	$137.9K
YoY Change	239.05%	47.48%	47.48%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$21.59M	$18.78M	$18.78M
YoY Change	4.84%	307.8%	307.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$109.3K	$118.3K	$118.3K
YoY Change
Goodwill	$345.7K	$345.7K
YoY Change		0.0%
Intangibles	$809.1K	$866.5K
YoY Change		-20.93%
Long-Term Investments
YoY Change
Other Assets	$4.562K	$4.562K	$4.560K
YoY Change
Total Long-Term Assets	$1.269M	$1.335M	$1.335M
YoY Change	-8.35%	-7.39%	-7.39%
TOTAL ASSETS
Total Short-Term Assets	$21.59M	$18.78M	$18.78M
Total Long-Term Assets	$1.269M	$1.335M	$1.335M
Total Assets	$22.86M	$20.11M	$20.11M
YoY Change	4.01%	232.65%	232.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.622M	$2.443M	$2.443M
YoY Change	285.98%	145.17%	145.17%
Accrued Expenses	$40.32K	$38.88K	$38.88K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.096M	$4.169M	$4.169M
YoY Change	225.04%	318.44%	318.44%
LONG-TERM LIABILITIES
Long-Term Debt	$12.73M	$12.14M	$12.14M
YoY Change
Other Long-Term Liabilities		$48.39K	$135.8K
YoY Change
Total Long-Term Liabilities	$0.00	$48.39K	$12.27M
YoY Change	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.096M	$4.169M	$4.169M
Total Long-Term Liabilities	$0.00	$48.39K	$12.27M
Total Liabilities	$16.90M	$16.44M	$16.44M
YoY Change	868.98%	1550.36%	1550.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$261.4M	-$251.0M
YoY Change		11.6%
Common Stock	$267.3M	$254.6M
YoY Change		10.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.961M	$3.671M	$3.671M
YoY Change
Total Liabilities & Shareholders Equity	$22.86M	$20.11M	$20.11M
YoY Change	4.01%	232.65%	232.65%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022
OPERATING ACTIVITIES
Net Income	-$10.42M	-$8.089M	-$26.08M
YoY Change	87.98%	-93.85%	-79.97%
Depreciation, Depletion And Amortization	$57.34K	$57.35K	$229.4K
YoY Change	0.0%	-3.42%	0.0%
Cash From Operating Activities	-$9.220M	-$5.865M	-$18.99M
YoY Change	263.77%	-16.37%	81.68%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$18.51M
YoY Change			13.47%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$11.81M	0.000	$33.12M
YoY Change	-36.2%	-100.0%	121.88%
NET CHANGE
Cash From Operating Activities	-$9.220M	-5.865M	-$18.99M
Cash From Investing Activities
Cash From Financing Activities	$11.81M	0.000	$33.12M
Net Change In Cash	$2.589M	-5.865M	$14.13M
YoY Change	-83.79%	-14.32%	215.8%
FREE CASH FLOW
Cash From Operating Activities	-$9.220M	-$5.865M	-$18.99M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001580149
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2021Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2021Q2	bivi	Warrant Liabilities WarrantLiabilities		usd
CY2021Q2	bivi	Embedded Derivative Liability EmbeddedDerivativeLiability		usd
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2021Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	bivi	In Process Research And Development Expenses InProcessResearchAndDevelopmentExpenses		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	bivi	Deemed Dividend DeemedDividend		usd
CY2021	bivi	Deemed Dividend For Commitment Shares DeemedDividendForCommitmentShares		usd
CY2021	bivi	Cashless Exercise Of Options CashlessExerciseOfOptions		usd
CY2021	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock		usd
CY2022	bivi	Common Shares Issued For Asset Acquisition CommonSharesIssuedForAssetAcquisition		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2021	bivi	Accretion Of Loan Premium AccretionOfLoanPremium		usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities		usd
CY2022	bivi	Payment Of Convertible Debenture Related Party PaymentOfConvertibleDebentureRelatedParty		usd
CY2022	bivi	Proceeds From Convertible Debenture Related Party ProceedsFromConvertibleDebentureRelatedParty		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022	bivi	Deemed Dividend DeemedDividend		usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2021Q2	us-gaap	Notes Payable NotesPayable		usd
CY2021Q2	bivi	Accretion Of Loan Premiums AccretionOfLoanPremiums		usd
CY2021Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2021Q2	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability		usd
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent		pure
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39015
CY2022	dei	Entity Registrant Name EntityRegistrantName	BIOVIE INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-2510769
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	680 W Nye Lane
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 204
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Carson City
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89703
CY2022	dei	City Area Code CityAreaCode	(775)
CY2022	dei	Local Phone Number LocalPhoneNumber	888-3162
CY2022	dei	Security12b Title Security12bTitle	Class A common stock, $.0001 par value per share
CY2022	dei	Trading Symbol TradingSymbol	BIVI
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Public Float EntityPublicFloat	23348687	usd
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30165319	shares
CY2022	dei	Auditor Name AuditorName	EisnerAmper LLP
CY2022	dei	Auditor Location AuditorLocation	Iselin, New Jersey
CY2022	dei	Auditor Firm AuditorFirmId	274
CY2022Q2	us-gaap	Cash Cash	18641716	usd
CY2021Q2	us-gaap	Cash Cash	4511642	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	137879	usd
CY2021Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	93487	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	18779595	usd
CY2021Q2	us-gaap	Assets Current AssetsCurrent	4605129	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	118254	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	866472	usd
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1095849	usd
CY2022Q2	us-gaap	Goodwill Goodwill	345711	usd
CY2021Q2	us-gaap	Goodwill Goodwill	345711	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4562	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1334999	usd
CY2021Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1441560	usd
CY2022Q2	us-gaap	Assets Assets	20114594	usd
CY2021Q2	us-gaap	Assets Assets	6046689	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2442804	usd
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	996374	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1304925	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38884	usd
CY2022Q2	bivi	Warrant Liabilities WarrantLiabilities	194531	usd
CY2022Q2	bivi	Embedded Derivative Liability EmbeddedDerivativeLiability	188030	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4169174	usd
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	996374	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	48385	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87414	usd
CY2022Q2	bivi	Unearned Premium And Discount UnearnedPremiumAndDiscount	2861314	usd
CY2021Q2	bivi	Unearned Premium And Discount UnearnedPremiumAndDiscount	2861314	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	12138686	usd
CY2022Q2	us-gaap	Liabilities Liabilities	16443659	usd
CY2021Q2	us-gaap	Liabilities Liabilities	996374	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24984083	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24984083	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22333324	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22333324	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	2496	usd
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	2232	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	254638329	usd
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	229933505	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-250969890	usd
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-224885422	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3670935	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	5050315	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20114594	usd
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6046689	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	229377	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	229377	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17258341	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2544648	usd
CY2021	bivi	In Process Research And Development Expenses InProcessResearchAndDevelopmentExpenses	130642858	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9765259	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4637256	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	27252977	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	138054139	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-27252977	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-138054139	usd
CY2022	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	3287418	usd
CY2021	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	8279919	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	62500	usd
CY2022	us-gaap	Interest Expense InterestExpense	2162989	usd
CY2021	us-gaap	Interest Expense InterestExpense	559455	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	44080	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	21971	usd
CY2022	bivi	Total Other Expense Income TotalOtherExpenseIncome	-1168509	usd
CY2021	bivi	Total Other Expense Income TotalOtherExpenseIncome	-7804935	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-26084468	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-130249204	usd
CY2021	bivi	Deemed Dividend DeemedDividend	53598320	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-26084468	usd
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-183847524	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.06
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-14.82
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.06
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-14.82
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24662557	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12403159	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24662557	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12403159	shares
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-21498636	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2371790	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15628010	usd
CY2021	bivi	Redemption Of Warrants And Purchase Option Related Party RedemptionOfWarrantsAndPurchaseOptionRelatedParty	13132385	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3019809	usd
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	685302	usd
CY2021	bivi	Issuance Of Shares For Purchase Of In Process Research And Development Expenses Related Party IssuanceOfSharesForPurchaseOfInProcessResearchAndDevelopmentExpensesRelatedParty	124332649	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-130249204	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	5050315	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	5807871	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2224992	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18511009	usd
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	386208	shares
CY2022	us-gaap	Profit Loss ProfitLoss	-26084468	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3670935	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-26084468	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-130249204	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	229377	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	229377	usd
CY2022	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock	386208	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	5807871	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3019809	usd
CY2021	bivi	Common Shares Issued For Asset Acquisition CommonSharesIssuedForAssetAcquisition	124332649	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	62500	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	99295	usd
CY2022	bivi	Interest Expense From Convertible Debenture InterestExpenseFromConvertibleDebenture	-934177	usd
CY2021	bivi	Interest Expense From Convertible Debenture InterestExpenseFromConvertibleDebenture	-537275	usd
CY2022	bivi	Accretion Of Loan Premium AccretionOfLoanPremium	-165278	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	8044	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3287418	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	8279919	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	48954	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-282298	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1446430	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-262832	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1353310	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18990850	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10453047	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18511009	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15628010	usd
CY2021	bivi	Payment Of Convertible Debenture Related Party PaymentOfConvertibleDebentureRelatedParty	1821818	usd
CY2021	bivi	Proceeds From Convertible Debenture Related Party ProceedsFromConvertibleDebentureRelatedParty	436000	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	685302	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	14609915	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	33120924	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14927494	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	14130074	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	4474447	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4511642	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37195	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18641716	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4511642	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	964241	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	22180	usd
CY2021	bivi	Deemed Dividend DeemedDividend	53598320	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	130039	usd
CY2022Q2	bivi	Working Capital WorkingCapital	14600	usd
CY2022Q2	us-gaap	Cash Cash	18641716	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3670935	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-250969890	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_843_eus-gaap--UseOfEstimates_zoLux7RgMrji" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_86B_zTeZW2JHTdld">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances. The amounts of assets and liabilities reported in the Company’s balance sheet and the amounts of expenses reported for each of the periods presented are affected by estimates and assumptions, which are used for, but not limited to, accounting for share-based compensation and other equity instruments, accounting for derivatives and accounting for income taxes. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> </p>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84B_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zZxDN8UT6g49" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_866_zkFbLXLDPNAa">Reclassifications</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Certain prior period amounts have been reclassified for consistency to conform with the current year’s presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	178341	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	866472	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3398764	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	865775	shares
CY2020Q3	bivi	Common Stock Issued For Exercise Of Cashless Stock Options CommonStockIssuedForExerciseOfCashlessStockOptions	2210	shares
CY2020Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3200	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3909136	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	913961	shares
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	382561	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2293770	usd
CY2021Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2293770	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1427298	usd
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1197921	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	866472	usd
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1095849	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	229377	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	229377	usd
CY2022	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	229377	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	229377	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	229377	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1304925	usd
CY2022Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1161000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1400	usd
CY2022	bivi	Fair Value Of Embedded Conversion Option FairValueOfEmbeddedConversionOption	2200	usd
CY2022	bivi	Direct Financing Cost DirectFinancingCost	390000	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	850000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	2200	usd
CY2022	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	952000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	99000	usd
CY2022Q2	bivi	Unearned Discount UnearnedDiscount	934000	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	165000	usd
CY2022Q2	us-gaap	Notes Payable NotesPayable	15000000	usd
CY2022Q2	bivi	Debt Financing Costs DebtFinancingCosts	-290790	usd
CY2022Q2	us-gaap	Deferred Discounts Finance Charges And Interest Included In Receivables DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	2735802	usd
CY2022Q2	bivi	Accretion Of Loan Premiums AccretionOfLoanPremiums	165278	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	12138686	usd
CY2020Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.76
CY2021Q1	bivi	Common Stock Issued For Exercise Of Cashless Stock Options CommonStockIssuedForExerciseOfCashlessStockOptions	304	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	320	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.88
CY2021Q1	bivi	Common Stock Issued For Exercise Of Cashless Stock Options CommonStockIssuedForExerciseOfCashlessStockOptions	27000	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	27000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.50
CY2021Q1	bivi	Common Stock Issued For Exercise Of Cashless Stock Options CommonStockIssuedForExerciseOfCashlessStockOptions	14324	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	14324	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.50
CY2021Q2	bivi	Common Stock Issued For Exercise Of Cashless Stock Options CommonStockIssuedForExerciseOfCashlessStockOptions	724	shares
CY2021Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	760	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.88
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	89400	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	10000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	118254	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38884	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87414	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	126298	usd
CY2022	bivi	Schedule Of Future Estimated Minimum Lease Payments Under Non Cancelable Operating Leases ScheduleOfFutureEstimatedMinimumLeasePaymentsUnderNonCancelableOperatingLeases	<table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfFutureEstimatedMinimumLeasePaymentsUnderNonCancelableOperatingLeases_zFExayQ3jGHb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 1)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8BC_zkH1dwyGzPKk" style="display: none">Schedule of future estimated minimum lease payments under non-cancelable operating leases</span></td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td>Year ending June 30:</td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 70%; text-align: left; padding-left: 25.4pt">2023</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20220630_zDS6Q4mKxj27" style="width: 18%; text-align: right" title="2023">50,600</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left; padding-left: 25.4pt">2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20220630_pp0p0" style="text-align: right" title="2024">52,156</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt; padding-left: 25.4pt">2025</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20220630_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="2025">44,636</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Total minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20220630_z9NjyfD2nbqj" style="text-align: right" title="Total minimum lease payments">147,392</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 5.4pt">Less amount representing interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_ecustom--CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayment_iNI_pp0p0_di_c20220630_zzPxb0nA7ngi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less amount representing interest">(21,094</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Present value of future minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20220630_zLGde3IzWyJ1" style="text-align: right" title="Present value of future minimum lease payments">126,298</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 5.4pt">Less current portion of operating lease liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pp0p0_di_c20220630_zUc1ERozG6fh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less current portion of operating lease liabilities">(38,884</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 4pt; padding-left: 5.4pt">Operating lease liabilities, net of current portion</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_c20220630_z8MvksqRXE5i" style="border-bottom: Black 4pt double; text-align: right" title="Operating lease liabilities, net of current portion">87,414</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	50600	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	52156	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	44636	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	147392	usd
CY2022Q2	bivi	Capital Leases Future Minimum Payments Interest Included In Payment CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayment	21094	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	126298	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38884	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87414	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1075	pure
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	121000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	6410653	usd
CY2021Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	1454837	usd
CY2022Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-258209	usd
CY2021Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-327001	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1845836	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	901111	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7998280	usd
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2028947	usd
CY2022Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	7999280	usd
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2028947	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5969333	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	291741	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.09	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.09	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.30	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.30	pure

Files In Submission

Name	View Source	Status
0001520138-22-000437-index-headers.html	Edgar Link	pending
0001520138-22-000437-index.html	Edgar Link	pending
0001520138-22-000437.txt	Edgar Link	pending
0001520138-22-000437-xbrl.zip	Edgar Link	pending
bivi-20220630.xsd	Edgar Link	pending
bivi-20220630_10k.htm	Edgar Link	pending
bivi-20220630_10kex21z1.htm	Edgar Link	pending
bivi-20220630_10kex23z1.htm	Edgar Link	pending
bivi-20220630_10kex31z1.htm	Edgar Link	pending
bivi-20220630_10kex31z2.htm	Edgar Link	pending
bivi-20220630_10kex32z1.htm	Edgar Link	pending
bivi-20220630_10kex32z2.htm	Edgar Link	pending
bivi-20220630_cal.xml	Edgar Link	unprocessable
bivi-20220630_10k_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
bivi-20220630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bivi-20220630_def.xml	Edgar Link	unprocessable
bivi-20220630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BIVI
BIOVIE INC. Stock $bivi

2022 Q3 Form 10-K Financial Statement

#000152013822000437 Filed on September 27, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIVI BIOVIE INC. Stock $bivi

2022 Q3 Form 10-K Financial Statement

#000152013822000437 Filed on September 27, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIVI
BIOVIE INC. Stock $bivi